Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-   A9903 p53/MDM2 Set ISummary: For inhibiting MDM2-p53 interaction A9903 p53/MDM2 Set ISummary: For inhibiting MDM2-p53 interaction
-   B3255 MeisoindigoSummary: Apoptosis inducer;potential agent for AML B3255 MeisoindigoSummary: Apoptosis inducer;potential agent for AML
-   B6011 A-12104772 CitationTarget: Mcl-1Summary: MCL-1 inhibitor B6011 A-12104772 CitationTarget: Mcl-1Summary: MCL-1 inhibitor
-   C4468 NS3694Summary: inhibits apoptosome formation and caspase activation C4468 NS3694Summary: inhibits apoptosome formation and caspase activation
-   A8244 Cycloheximide54 CitationSummary: protein biosynthesis inhibitor A8244 Cycloheximide54 CitationSummary: protein biosynthesis inhibitor
-   A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2 inhibitor, novel A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2 inhibitor, novel
-   B3233 Z-LEHD-FMK8 CitationTarget: CaspasesSummary: Irreversible Caspase-9 inhibitor. B3233 Z-LEHD-FMK8 CitationTarget: CaspasesSummary: Irreversible Caspase-9 inhibitor.
-   B5978 BDA-366Target: Bcl-2Summary: Selective antagonist of BCL2 BH4 domain B5978 BDA-366Target: Bcl-2Summary: Selective antagonist of BCL2 BH4 domain
-   B3232 Z-IETD-FMK12 CitationTarget: CaspasesSummary: Caspase-8 inhibitor B3232 Z-IETD-FMK12 CitationTarget: CaspasesSummary: Caspase-8 inhibitor
-   B5846 Radotinib(IY-5511)Target: PDGFR|Bcr-AblSummary: Bcr-Abl tyrosine kinase inhibitor B5846 Radotinib(IY-5511)Target: PDGFR|Bcr-AblSummary: Bcr-Abl tyrosine kinase inhibitor

